Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.34 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | GSK3B | P49841 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | FURIN | P09958 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1147590 | 1.00 | LMNA (0.39) | LMNAL3MBTL1MAPK1HTTSMN1; SMN2 | |
| SCHEMBL9411077 | 1.00 | LMNA (0.39) | LMNAL3MBTL1MAPK1HTTSMN1; SMN2 | |
| SCHEMBL12750110 | 0.84 | LMNA (0.48) | LMNAL3MBTL1MAPK1HTTSMN1; SMN2 | |
| SCHEMBL5958328 | 0.78 | LMNA (0.48) | LMNAL3MBTL1MAPK1HTTSMN1; SMN2 | |
| SCHEMBL5958327 | 0.78 | LMNA (0.48) | LMNAL3MBTL1MAPK1HTTSMN1; SMN2 | |
| SCHEMBL5958142 | 0.78 | LMNA (0.36) | LMNAL3MBTL1MAPK1HTTSMN1; SMN2 | |
| SCHEMBL5958145 | 0.78 | LMNA (0.36) | LMNAL3MBTL1MAPK1HTTSMN1; SMN2 | |
| SCHEMBL18543666 | 0.78 | LMNA (0.36) | LMNAL3MBTL1MAPK1HTTSMN1; SMN2 | |
| SCHEMBL5732924 | 0.77 | LMNA (0.63) | LMNAL3MBTL1MAPK1HTTSMN1; SMN2 | |
| SCHEMBL2615557 | 0.77 | LMNA (0.63) | LMNAL3MBTL1MAPK1HTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0581464-A1 | Ester derivatives and pharmaceutical compositions containing them | ZENECA LIMITED (GB) | 1994-02-02 | — | — | EP | claimed |
| EP-2640707-B1 | 5-HALOGENOPYRAZOLECARBOXAMIDES | BAYER IP GMBH (DE) | 2017-03-15 | — | — | EP | disclosed |
| EP-2010514-B1 | 3-(PYRIDIN-2-YL)-[1,2,4]-TRIAZINES FOR USE AS FUNGICIDES | BASF SE (DE) | 2010-12-29 | — | — | EP | disclosed |
| US-20090111692-A1 | 3-(Pyridin-2-Yl)-[1,2,4]-Triazines as Fungicides | BASF AKTIENGESELLSCHAFT (DE) | 2009-04-30 | — | — | US | disclosed |
| US-20090105072-A1 | 2-(Pyridin-2-Yl)-Pyrimidines for Use as Fungicides | BASF SE (DE) | 2009-04-23 | — | — | US | disclosed |
| EP-2010515-A1 | 2-(PYRIDIN-2-YL)-PYRIMIDINES FOR USE AS FUNGICIDES | BASF SE (DE) | 2009-01-07 | — | — | EP | disclosed |
| EP-2010514-A1 | 3-(PYRIDIN-2-YL)-[1,2,4]-TRIAZINES FOR USE AS FUNGICIDES | BASF SE (DE) | 2009-01-07 | — | — | EP | disclosed |
| WO-2007116079-A1 | 2-(PYRIDIN-2-YL)-PYRIMIDINES FOR USE AS FUNGICIDES | BASF SE (DE) | 2007-10-18 | — | — | WO | disclosed |
| WO-2007116078-A1 | 3-(PYRIDIN-2-YL)-[1,2,4]-TRIAZINES FOR USE AS FUNGICIDES | BASF SE (DE) | 2007-10-18 | — | — | WO | disclosed |
| US-20060122065-A1 | Amide compound and method of controlling plant disease with the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-06-08 | — | — | US | disclosed |
| EP-1577290-A1 | AMIDE COMPOUND AND METHOD OF CONTROLLING PLANT DISEASE WITH THE SAME | Sumitomo Chemical Company, Limited (JP) | 2005-09-21 | — | — | EP | disclosed |
| US-20050101783-A1 | N-(heterocycle-methyl)alkylamine derivative, process for producing the same, and bactericide | KUREHA CORPORATION (JP) | 2005-05-12 | — | — | US | disclosed |
| EP-0581464-A1 | Ester derivatives and pharmaceutical compositions containing them | ZENECA LIMITED (GB) | 1994-02-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090111692-A1 | 3-(Pyridin-2-Yl)-[1,2,4]-Triazines as Fungicides | CBR3, CBR1, TH | LMNA 3387/4885L3MBTL1 1295/4885MAPK1 2424/4885 |
| US-20050101783-A1 | N-(heterocycle-methyl)alkylamine derivative, process for producing the same, and bactericide | HBZ, ACMSD, HDHD5 | LMNA 2729/4885L3MBTL1 1563/4885MAPK1 1370/4885 |
| US-20060122065-A1 | Amide compound and method of controlling plant disease with the same | CBR3, C5, CLN6 | LMNA 2837/4885L3MBTL1 12/4885MAPK1 2669/4885 |
| US-20090105072-A1 | 2-(Pyridin-2-Yl)-Pyrimidines for Use as Fungicides | CBR3, CBR1, CNPY2 | LMNA 3547/4885L3MBTL1 1316/4885MAPK1 3777/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.